Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Senior Manager
Telephone: 412-578-9193 or 412-624-3212
Manager
Telephone: 412-623-4701 or 412-586-9773
Other Inquiries

University of Pittsburgh Schools of the Health Sciences

Pitt Team Finds Protein That Keeps Balance Between Tumor Cell Growth and Suppression

PITTSBURGH, Jan. 27, 2012 – Using an  approach that combines molecular biology, genetics, cell biology and physiology, and pathology, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine have identified a protein that governs a key molecule involved in orchestrating the balance between tumor growth and tumor suppression. The findings, published today in Molecular Cell, reveal a regulatory pathway that could provide new targets for future cancer treatment.

Kruppel-like factor 4 (KLF4) is one of four molecules known to play an important role in transforming the body’s mature cells back into stem cells, said senior author Yong Wan, Ph.D., associate professor, Department of Cell Biology, Pitt School of Medicine and UPCI. His team began studying KLF4 to better understand its biology.

“This molecule has been shown in other studies to encourage tumor growth in some cases, such as breast cancer, but to suppress it in others, such as gastrointestinal cancer,” he said. “We wanted to learn how that was possible.”

From a cultured cancer-cell line, the researchers began purifying proteins and examining their interactions using sophisticated combinatorial techniques. They found that a protein made by the von Hippel-Lindau gene (pVHL) binds to KLF4 and triggers a biochemical pathway that leads to KLF4’sdegradation.

Dr. Wan noted that KLF4 determines cell fate by activating or inhibiting a network of genes involved in cellular functions as diverse as cell cycle regulation and metabolism, stem cell renewal and cell death.  In some cells, it leads to production of proteins that suppress cell proliferation. That means pVHL performs a balancing act: if it is high, the lifespan of KLF4 shortens; if it is low, KLF4 lasts longer, with a consequent impact on the number of cells.

“In colon cancer cells, pVHL levels are high and KLF4 is low, which suggest promotion of tumor cell growth,” he said. “But our other research shows that in breast cancer, KLF4 is high. The abnormal proteins produced by cancer cells could be influencing this pathway, so we are working to better understand these processes.”

Learning more about the role of pVHL, KLF4 and other proteins that interact with them could also lead to new cancer drugs, the researchers said.

Co-authors of the paper include Armin M. Gamper, Ph.D., Xinxian Qiao and Liyong Zhang, Ph.D., of the Department of Cell Biology, Pitt School of Medicine, and UPCI; Jennifer Kim of Carnegie Mellon University; and Michelle C. DeSimone and W. Kimryn Rathmell, M. D., Ph.D., of the University of North Carolina. The research was funded by National Institutes of Health grants CA154695 and CA115943 and the American Cancer Society.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com